Table 2.
Pathological details.
| Total n = 367 (%) | Leak Group n = 64 (%) | No Leak Group n = 303 (%) | p | |
|---|---|---|---|---|
| pT | ||||
| pT0 | 43 (11.9) | 6 (9.4) | 37 (12.5) | 0.04 |
| pT1 | 38 (10.5) | 9 (14) | 29 (9.6) | |
| pT2 | 71 (19.4) | 5 (7.8) | 66 (21.8) | |
| pT3 | 191 (51.5) | 37 (57.8) | 154 (50.8) | |
| pT4 | 24 (6.7) | 7 (11) | 17 (5.3) | |
| pN | ||||
| pN0 | 240 (65.4) | 38 (59.4) | 201 (66.5) | 0.26 |
| pN1 | 84 (22.9) | 16 (25) | 68 (22.5) | |
| pN2 | 43 (11.7) | 10 (15.6) | 34 (11) | |
| Harvested lymph nodes mean (± SD) | 20.52 (±10.6) | 22 (±9.6) | 20.3 (±10.6) | 0.33 |
| Stage | ||||
| I-II | 240 (65.4) | 38 (59.4) | 202 (66.7) | 0.27 |
| III-IV | 127 (34.6) | 26 (40.6) | 101 (33.4) | |
Bold values indicate statistical significance.